Clindamycin Phosphate Gel
NDC Package 0168-0202-60
Package Information
Clindamycin Phosphate gel is a medication used to treat acne. This formulation utilizes a gel delivery system. Marketed by E. Fougera & Co. A Division Of Fougera Pharmaceuticals, Llc, this product is identified by NDC 0168-0202 and is authorized under FDA application ANDA064160.
Identification & Billing
- RxCUI: 197519 - clindamycin phosphate 1 % Topical Lotion
- RxCUI: 197519 - clindamycin 10 MG/ML Topical Lotion
- RxCUI: 197519 - clindamycin (as clindamycin phosphate) 1 % Topical Lotion
- RxCUI: 197519 - clindamycin 1 % Topical Lotion
- RxCUI: 2676585 - clindamycin phosphate 1 % Twice-Daily Topical Gel
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0168 - E. Fougera & Co. A Division Of Fougera Pharmaceuticals, Llc
- 0168-0202 - Clindamycin Phosphate
- 0168-0202-60 - 1 TUBE in 1 CARTON / 60 g in 1 TUBE
- 0168-0202 - Clindamycin Phosphate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0168-0202). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0168-0202-60 identifies a specific commercial package of 1 tube in 1 carton / 60 g in 1 tube of Clindamycin Phosphate, a human prescription drug labeled by E. Fougera & Co. A Division Of Fougera Pharmaceuticals, Llc. This gel is formulated for topical use and contains clindamycin phosphate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by E. Fougera & Co. A Division Of Fougera Pharmaceuticals, Llc on January 28, 2000. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used to treat acne. It helps to decrease the number of acne lesions. Clindamycin is an antibiotic which works by stopping the growth of bacteria.
How is this E. Fougera & Co. A Division Of Fougera Pharmaceuticals, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00168020260. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.